FindTrial
Sign In

A Prospective Randomized Controlled Trial of Single Microneedle Radiofrequency for Moderate to Severe Acne Vulgaris

Comparison of efficacy of single micronewlet radiofrequency therapy vs photodynamic therapy for treatment of moderate acne vulgaris: a prospective, blind, randomized, and controlled trial

Status
Recruiting
Phases
Unknown
Study type
Interventional
Source
ITMCTR
Registry ID
ITMCTR1900002880
Enrollment
Unknown
Registered
2019-12-29
Start date
2019-12-30
Completion date
Unknown
Last updated
2023-02-20

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Acne

Interventions

group B :photodynamic therapy
group A :micronewlet radiofrequency

Sponsors

Xiangya Hospital Central South University
Lead Sponsor

Eligibility

Sex/Gender
All
Age
14 Years to 45 Years

Inclusion criteria

Inclusion criteria: 1. Consistent with the diagnostic criteria of moderate-to-severe acne vulgaris (IGA3-4) . 2. Age of a subject is older than 14 and is younger than 45. 3. Did not take any anti-acne treatment in the last 1 month, and did not take part in any clinical trial. 4. Informed consent is signed by a subject or his lineal relation.

Exclusion criteria

Exclusion criteria: 1. Systemic acne treatment with oral isotretinoin within 6 months or oral antibiotics in the past 1 month; 2. History of photosensitive diseases, porphyria, or porphyrin sensitivity. 3. With serious protopathy or disease of cardiovascular, liver, renal, gastrointestinal, hematological systems and so on. 4. Pregnant women or women in lactation.

Design outcomes

Primary

MeasureTime frame
lesion counts;—

Secondary

MeasureTime frame
QLDI;IGA;—

Countries

China

Contacts

Public ContactDan Jian

Xiangya Hospital Central South University

780905919@qq.com+86 13787117041

Outcome results

None listed

Source: ITMCTR (via WHO ICTRP) · Data processed: Feb 4, 2026